i
Important informations

LDI

The Lady Davis Institute for Medical Research

The research arm of the Jewish General Hospital

The LDI is among Canada’s leading health research institutes. Through their fundamental and clinical investigations, our scientists and clinicians make significant discoveries, lead important provincial and national research programs, and train emerging scientists who, themselves, are recognized for the excellence of their work, contributing to the health and well-being of patients in Quebec, Canada, and around the world.

Empowering research excellence and innovation

At the Lady Davis Institute for Medical Research (LDI), equity, diversity and inclusion are at the heart of who we are. We are committed to provide people working in the LDI community with exemplary, highest quality of work and learning environments that are healthy, equitable and inclusive, free from all forms of discrimination and where every person can feel welcomed and recognized, but also involved and contributing to the present and the future of the LDI.

Discover our 200+ regular and associated investigators and their research, as well as the many services we provide across the spectrum of the research process.

We offer the 250+ graduate and postdoctoral students who come to the LDI each year an open, collaborative, and multidisciplinary training environment that fosters excellence.

The close collaboration between researchers, clinicians, and patients is at the basis of the most successful research programs and clinical trials at the LDI.

Empowering research excellence and innovation

At the Lady Davis Institute for Medical Research (LDI), equity, diversity and inclusion are at the heart of who we are. We are committed to provide people working in the LDI community with exemplary, highest quality of work and learning environments that are healthy, equitable and inclusive, free from all forms of discrimination and where every person can feel welcomed and recognized, but also involved and contributing to the present and the future of the LDI.

Latest News

Seminars

Events

Tweets

Psychosocial aspects of disease

Anxiety, Coping, Depression, Emotion regulation, Perfectionism, Self-criticism, Stress

Cancer

Breast cancer, Cancer predisposition, DICER1 Tumour Predisposition Syndrome (DTPS), Founder populations, Gene discovery, Genetic testing, Genetic variants, Multiple primary tumours

Molecular & Regenerative Medicine

Cardiac surgery, Echocardiography, Gut microbiome and metabolome, Inflammation, Myocardial infarction, Resistant starch diet, Sex-dependent response, Total western diet

Cancer

Arginine methylation and DNA damage, Breast cancer epigenetics, Drug design, RGG/RG motifs and G-quadruplexes, RNA binding proteins and neurological diseases

Cancer

Breast cancer, Immune suppression, Inflammation, Melanoma, Metabolic reprogramming, mRNA translation, Oxidative stress, Signal transduction, Transgenic mouse models

Clinical Epidemiology

Chronic diseases, COPD, Data science, Drug safety and effectiveness, Observational studies, Pharmacoepidemiology, Real-world evidence, Research methods

Cancer

Atypical ductal hyperplasia, Atypical lobular hyperplasia, BRCA 1/2, Breast cancer susceptibility genes, Chemoprevention, Endocrine prevention, Lobular carcinoma in situ, Mainstream genetic testing, Prophylactic mastectomy, Risk reducing mastectomy

Cancer

Brain tumor microenvironment, Cancer, Drug discovery, Drug therapeutics, Fundamental research, Immunology, Innate immune cell recruitment, Neuroscience, Organ-selective metastasis, p75 neurotrophin receptor (CD271) in tumorigenesis, Pediatrics

National Collaborations and Partnerships